Responses of Contracted Airways and Parenchyma to Stretch in Vivo
体内收缩气道和实质对拉伸的反应
基本信息
- 批准号:7392278
- 负责人:
- 金额:$ 48.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAirAnti-Inflammatory AgentsAnti-inflammatoryAreaAsthmaAttenuatedBasement membraneBehaviorBiopsyBreathingBronchodilator AgentsChemicalsCollagenConstriction procedureContractsDataDepthDilatorDimensionsDiseaseEconomic InflationEdemaElastinEnvironmentEnzymesEquilibriumEtiologyExcisionFunctional disorderHigh Resolution Computed TomographyImageIndividualInflammationInflammatoryLocal anesthesiaLocationLungMatrix MetalloproteinasesMeasurementMeasuresMethodsMuscle TonusNational Research Service AwardsNerveNormal salineNumbersObstructionOralPharmaceutical PreparationsProcessPropertyPulmonary function testsRangeRelaxationResistanceSeveritiesSeverity of illnessSiteSmooth MuscleStressStretchingStructural ProteinStructureStructure of parenchyma of lungTenascinTestingTotal Lung CapacityTreesairway hyperresponsivenessairway remodelingasthmatic airwaybasedesignelectric impedancein vivointravenous administrationneuromechanismnovelpneumococcal purpura-producing principleprogramsrelating to nervous systemrespiratory smooth muscleresponsesize
项目摘要
It has been suggested that the airway contractile response of asthmatic subjects to a deep inspiration, compared to normal airway dilation seen in healthy subjects, reflects an intrinsic pathophysiology of this disease. Although it is clear that properties of airway smooth muscle must be involved in this functional difference, the properties of the parenchyma that surround the airways may be equally important. This fact suggests that a significant problem in asthma may be related to airway smooth muscle behavior in its dynamic parenchymal environment. This proposal will evaluate mechanisms that underlie this parenchymal-airway interaction, particularly focused on the response to lung inflation and deep inspiration with contracted smooth
muscle. This project contains several unique approaches to provide new information on how the lung responds to distension in vivo. First we use a novel method of challenging individual airways that allows us to separate the effects of agonist stimulation on individual airways, the entire airway tree, or the lung parenchyma. Second, by simultaneously using CT imaging with lung impedance measurements, we will be able to completely characterize the airway and dynamic parenchymal viscous and elastic responses. Third, by using a novel challenge method to anesthetize local airway nerves, we can determine how these nerves interact to determine
whether the airway will respond with a contraction or relaxation following a deep inspiration. Specific aims of this proposal are designed to test two primary hypotheses related to this airway-parenchymal interaction in vivo: 1) The resultant behavior of airways following lung inflation depends on a balance between opposing physical and chemical effects on the smooth muscle; 2) parenchymal contraction can limit the ability of airways to narrow with pharmacologic or inflation stresses.
已经表明,与健康受试者中观察到的正常气道扩张相比,哮喘受试者对深吸气的气道收缩反应反映了这种疾病的内在病理生理学。虽然很明显,气道平滑肌的性质必须参与这种功能差异,气道周围的实质的性质可能同样重要。这一事实表明,哮喘的一个重要问题可能与气道平滑肌在其动态实质环境中的行为有关。该建议将评估这种实质-气道相互作用的基础机制,特别关注肺膨胀和收缩平滑的深吸气的反应。
肌肉.该项目包含几种独特的方法,以提供有关肺如何对体内扩张做出反应的新信息。首先,我们使用一种新的方法来挑战单个气道,使我们能够分离激动剂刺激对单个气道、整个气道树或肺实质的影响。其次,通过同时使用CT成像与肺阻抗测量,我们将能够完全表征气道和动态实质粘性和弹性响应。第三,通过使用一种新的激发方法麻醉局部气道神经,我们可以确定这些神经如何相互作用,以确定
呼吸道在深吸气后是否会收缩或舒张。本提案的具体目的旨在测试与体内气道-实质相互作用相关的两个主要假设:1)肺膨胀后气道的最终行为取决于对平滑肌的相反物理和化学作用之间的平衡; 2)实质收缩可限制气道在药理学或膨胀应力下变窄的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wayne Mitzner其他文献
Wayne Mitzner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wayne Mitzner', 18)}}的其他基金
Mechanism of pathogenic macrophage activation in emphysema
肺气肿致病性巨噬细胞激活机制
- 批准号:
10084710 - 财政年份:2018
- 资助金额:
$ 48.18万 - 项目类别:
Responses of Contracted Airways and Parenchyma to Stretch in Vivo
体内收缩气道和实质对拉伸的反应
- 批准号:
7312427 - 财政年份:2006
- 资助金额:
$ 48.18万 - 项目类别:
Responses of Contracted Airways and Parenchyma to Stretch in Vivo
体内收缩气道和实质对拉伸的反应
- 批准号:
6967823 - 财政年份:2004
- 资助金额:
$ 48.18万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 48.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 48.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 48.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)